Home / Products / Aluminum-Plastic Caps / Aluminum-Plastic Cap for Injection Vials

Certificate Of Honor
  • DRUG MASTER FILE
  • ISO 9001
  • ISO 14001
  • ISO 45001
  • CERTIFICATE FOR MEASUEMENT QUALIFIED
  • CDE REGISTRATION NUMBER
News
  • Euro PP caps — short for European-standard polypropylene caps — are pharmaceutical-grade polypropylene closures designed to seal infusion bottles, oral liquid bottles, and other pharmaceutical containers in compliance with European pharmacopoeial and packaging standards. They are molded from medical-grade polypropylen...

    READ MORE
  • Aluminum-plastic caps are used primarily in pharmaceutical packaging to seal and secure containers including injection vials, large-volume infusion bottles, and oral liquid bottles — protecting the drug product from contamination, maintaining sterility, preventing leakage, and providing tamper evidence throughout the ...

    READ MORE
  • In pharmaceutical manufacturing, the closure system is one of the most consequential decisions a packaging engineer will make. PP containers for contact lens packaging must do far more than simply hold a lens — they must maintain sterility from the moment of manufacture through the point of patient use, preserve the s...

    READ MORE
Aluminum-Plastic Cap for Injection Vials Industry knowledge
Jiangsu Changjiang Lids Co., Ltd. was

Wholesale Aluminum-Plastic Cap for Injection Vials Manufacturer

, founded in March 2000, with a registered capital of 45.68 million yuan, located in the beautiful center of the Yangtze River Delta in Yangzhong, Jiangsu Province. Changjiang Lids has been in manufacturing pharmaceutical packaging industry since 2000. It is a production-oriented enterprise specializing in high-quality pharmaceutical packaging, covering an area of 20,000 square meters.

An aluminum-plastic cap for injection vials is a composite primary pharmaceutical packaging component consisting of an outer aluminum shell crimped over an inner plastic (typically polypropylene or polyethylene) insert and a rubber stopper. Together, these elements form a tamper-evident, hermetically sealed closure system that protects injectable drug products — including vaccines, antibiotics, lyophilized formulations, and biologics — from contamination, leakage, and environmental degradation throughout their entire shelf life.

The aluminum component provides mechanical strength and a visible tamper-evidence feature upon removal, while the plastic insert acts as a protective interface between the aluminum and the rubber stopper, preventing direct metal-to-drug contact and reducing particulate risk. As a result, the aluminum-plastic cap for injection vials has become the industry-standard closure solution for parenteral packaging worldwide.

Jiangsu Changjiang Lids Co., Ltd. has been manufacturing pharmaceutical-grade aluminum-plastic caps since 2000, with an annual production capacity of 3 billion aluminum and aluminum-plastic caps, all produced in GMP-compliant C+A level cleanrooms.

Product Structure & Working Principle

Understanding the layered construction of an aluminum-plastic cap helps clarify its sealing performance and compatibility requirements:

Three-Layer Composite Structure

  1. Outer Aluminum Shell — Typically made from 8011 or 1060 aluminum alloy, the shell is crimped mechanically onto the vial neck. The aluminum provides rigidity, tamper evidence (the flip-off tab tears away on first opening), and a professional appearance suitable for label printing or embossing.
  2. Inner Plastic Insert (Button/Disc) — Molded from pharmaceutical-grade polypropylene (PP) or low-density polyethylene (LDPE), the plastic insert sits within the aluminum shell. It cushions the rubber stopper, prevents direct aluminum-to-stopper abrasion, and enables the flip-off or tear-off opening mechanism without exposing the stopper to sharp metal edges.
  3. Rubber Stopper Interface — Although the rubber stopper is a separate component, the aluminum-plastic cap is designed to work in precise dimensional tolerance with standardized stoppers (e.g., ISO 8362-2). The cap assembly maintains compression on the stopper to preserve hermetic integrity.

Sealing Mechanism

During filling and stoppering on a pharmaceutical production line, the rubber stopper is inserted into the vial neck. The aluminum-plastic cap assembly is then placed over the stopper and mechanically crimped using a capping machine. The crimping deforms the aluminum skirt beneath the vial neck flange, locking the assembly in place. The combination of stopper compression and crimped aluminum creates a hermetic seal that prevents microbial ingress, gas exchange, and moisture penetration.

Key Performance Parameters

Pharmaceutical customers evaluate aluminum-plastic caps against a defined set of functional and regulatory performance criteria. The table below summarizes the most critical parameters:

Table 1: Key Performance Parameters for Aluminum-Plastic Caps for Injection Vials
Parameter Typical Requirement Test Method Significance
Sealing Integrity No leakage at ≥0.06 MPa vacuum YBB 00122003 / USP <1207> Prevents contamination and preserves sterility
Dimensional Tolerance ±0.2 mm on critical dimensions ISO 8362-3 / GB/T 12255 Ensures compatibility with standard vials and capping machines
Crimp Force Resistance ≥50 N pull-off force after crimping Internal tensile test Tamper evidence and transport integrity
Particulate Contamination ≤20 particles ≥10 µm per cap Light obscuration / microscopy Critical for injectable drug safety
Heavy Metal Content Below ICH Q3D limits ICP-MS analysis Regulatory compliance for patient safety
Sterility / Bioburden Meets pharmacopeial requirements USP <71> / EP 2.6.1 Required for direct contact packaging
Flip-Off Tab Removal Force 15–35 N Force gauge test User safety and tamper-evidence balance

Product Variants & Specifications

Aluminum-plastic caps for injection vials are available in a range of standard sizes and opening configurations to match different vial neck diameters and clinical use scenarios. CHANGJIANG LIDS supplies the full spectrum of standard variants as well as custom specifications.

Table 2: Common Aluminum-Plastic Cap Size and Configuration Variants
Cap Outer Diameter Nominal Vial Neck (mm) Opening Type Typical Application
13 mm 13 Flip-off / Tear-off Small-volume parenterals, antibiotics
20 mm 20 Flip-off / Tear-off Vaccines, lyophilized products, biologics
28 mm 28 Flip-off / Tear-off Larger-volume injectables, powder vials
32 mm 32 Tear-off High-volume injectables, hospital pharmacy

Opening Configuration Comparison

Table 3: Flip-Off vs. Tear-Off Cap Configuration Comparison
Feature Flip-Off Cap Tear-Off Cap
Opening Method Plastic button flipped up to expose stopper Aluminum tab torn away completely
Stopper Access Needle puncture through exposed stopper Stopper fully accessible after tear-off
Tamper Evidence High — flip tab cannot be resealed High — tear cannot be reversed
Common Use Vaccines, multi-dose vials, biologics Single-use injectables, hospital use
Capping Machine Compatibility Standard rotary/linear crimpers Standard rotary/linear crimpers
Color Coding Available (plastic button) Limited (aluminum surface)

Application Scenarios

The aluminum-plastic cap for injection vials serves a wide variety of parenteral drug product segments. Below are representative application examples across therapeutic categories:

Vaccines

Vaccine vials — including multi-dose presentations for influenza, COVID-19, hepatitis B, and other immunizations — rely on aluminum-plastic caps to maintain sterility across multiple needle insertions. The flip-off configuration allows repeated puncture while the crimped aluminum skirt maintains seal integrity and provides visible evidence if the vial has been tampered with.

Antibiotic Powder for Injection

Lyophilized or crystalline antibiotic powders (e.g., penicillin, cephalosporins) require hermetic closures that prevent moisture ingress — a key cause of product degradation. The aluminum-plastic cap provides a moisture barrier, with the plastic insert preventing direct aluminum contact with moisture-sensitive formulations.

Biologics & Lyophilized Products

Biologics such as monoclonal antibodies and lyophilized proteins require packaging with minimal extractables and leachables. CHANGJIANG LIDS manufactures caps using pharmaceutical-grade materials that comply with ICH Q3D elemental impurity guidelines, supporting compatibility studies and regulatory dossier submissions.

Small-Volume Parenterals (SVP)

Vials for anesthetics, analgesics, contrast agents, and other SVPs with volumes from 1 mL to 50 mL are sealed with 13 mm or 20 mm aluminum-plastic caps. High-speed automated filling lines require caps with consistent dimensional tolerances to ensure reliable capping machine throughput exceeding 30,000 vials/hour.

Aluminum-Plastic Cap vs. Pure Aluminum Cap: Detailed Comparison

Pharmaceutical manufacturers choosing between aluminum-plastic caps and conventional all-aluminum caps should consider the following performance and operational differences:

Table 4: Aluminum-Plastic Cap vs. Pure Aluminum Cap — Head-to-Head Comparison
Comparison Dimension Aluminum-Plastic Cap Pure Aluminum Cap
Stopper Protection High — plastic insert cushions stopper Moderate — direct metal-to-stopper contact
Particulate Risk Lower — plastic prevents aluminum abrasion Higher — metal-to-rubber abrasion possible
Opening Convenience Flip-off plastic button — fingertip operation Requires cap opener tool in some designs
Color Coding Options Wide — plastic button available in many colors Limited — surface lacquer only
Regulatory Trend Preferred by modern pharmacopeias for injectables Still used for some oral liquid/infusion formats
Compatibility with Lyophilization Excellent — designed for lyophilized vials Less optimized
Unit Cost Slightly higher (composite material) Lower

Regulatory Standards & Compliance

Aluminum-plastic caps for injection vials are subject to rigorous national and international pharmaceutical packaging standards. CHANGJIANG LIDS designs and manufactures all products to comply with the following regulatory frameworks:

  • China National Standard: YBB 00122003 (Aluminum Cap for Pharmaceutical Use), GB/T 12255
  • International Standard: ISO 8362-3 (Aluminium caps for injection vials)
  • European Pharmacopoeia (EP): Ph. Eur. 3.2.5 (Tamper-evident packaging for injectable products)
  • US Pharmacopeia (USP): USP <660> Containers — Glass, USP <1207> Package Integrity Evaluation
  • GMP Compliance: Manufactured in C+A cleanroom per China GMP and ICH Q7 guidelines
  • Quality System: ISO 9001:2015 certified quality management system

CHANGJIANG LIDS maintains complete traceability documentation for raw materials, in-process quality data, and finished product release testing, supporting customer regulatory submissions including Drug Master Files (DMF) and CEP applications.

Quality Inspection & Testing Protocol

Every batch of aluminum-plastic caps undergoes a multi-stage quality inspection program before shipment. The following table outlines the standard testing protocol:

Table 5: Standard Quality Inspection Protocol for Aluminum-Plastic Caps
Inspection Stage Test Item Acceptance Criterion Frequency
Incoming Raw Material Aluminum alloy grade, PP resin certification CoA match; no heavy metals above limits Every lot
In-Process Dimensions, visual defects, assembly fit Per AQL 1.0 sampling plan Every production shift
Finished Product Seal integrity, flip-off force, appearance 100% visual; statistical seal test Every batch
Periodic Testing Extractables, bioburden, particulates Per pharmacopeial limits Quarterly / per customer agreement

Storage, Handling & Maintenance Guidelines

Proper storage and handling of aluminum-plastic caps prior to use on the filling line is essential to maintaining product quality and regulatory compliance.

Storage Conditions

  • Store in original sealed packaging at 15–30°C, relative humidity ≤60%.
  • Keep away from direct sunlight and sources of chemical contamination.
  • Shelf life is typically 24 months from manufacture date when stored correctly.
  • Store in a dedicated pharmaceutical packaging warehouse, separated from non-pharmaceutical materials.

Pre-Use Handling

  • Transfer caps from storage to the cleanroom environment through appropriate airlocks and depyrogenation procedures if required.
  • Inspect for transport damage (dents, loose plastic inserts, discoloration) before loading into capping hoppers.
  • Do not open packaging until caps are ready for use; once opened, use within the period specified in your validated process.

Capping Machine Maintenance

  • Verify crimping head dimensions match cap size at each product changeover.
  • Monitor crimp quality (residual seal force, cap tilt angle) at defined intervals during production runs.
  • Schedule preventive maintenance per equipment manufacturer guidelines to prevent seal integrity failures.

Frequently Asked Questions (FAQ)

Q1: What is the difference between an aluminum-plastic cap and a plain aluminum cap for injection vials?

An aluminum-plastic cap incorporates a molded plastic (typically polypropylene) insert inside the aluminum shell. This insert cushions the rubber stopper, reduces the risk of aluminum particulates from metal-to-rubber abrasion, and enables a convenient flip-off opening mechanism. A plain aluminum cap lacks the plastic insert, resulting in direct metal-to-stopper contact. For modern injectable drug packaging — particularly vaccines and biologics — the aluminum-plastic cap is the preferred format due to its superior particulate performance and user convenience.

Q2: What sizes of aluminum-plastic caps does CHANGJIANG LIDS supply?

CHANGJIANG LIDS supplies aluminum-plastic caps in standard diameters of 13 mm, 20 mm, 28 mm, and 32 mm, corresponding to the most widely used injection vial neck finishes per ISO 8362 and Chinese pharmacopeial standards. Custom sizes and colors are available on request, with tooling support from our in-house technical team.

Q3: Are the caps compatible with standard pharmaceutical filling and capping lines?

Yes. CHANGJIANG LIDS aluminum-plastic caps are manufactured to ISO 8362-3 dimensional tolerances, ensuring compatibility with rotary and linear capping equipment from major manufacturers including Bausch+Ströbel, IMA, Groninger, and others. All critical dimensions are controlled within ±0.2 mm to support high-speed automated capping at rates exceeding 30,000 vials/hour.

Q4: What cleanroom grade are the caps manufactured in?

All aluminum-plastic caps for injection vials at CHANGJIANG LIDS are produced in C+A level cleanrooms, which correspond to ISO Class 7 background with ISO Class 5 critical zones. This exceeds the minimum requirements for primary pharmaceutical packaging and ensures low bioburden and particulate levels upon delivery.

Q5: Can aluminum-plastic caps be color-coded for product differentiation?

Yes. The plastic insert (flip-off button) can be produced in a wide range of colors using pharmaceutical-grade masterbatches that comply with regulatory requirements for direct contact packaging. Color coding is commonly used by pharmaceutical companies to differentiate drug concentrations, vial volumes, or product lines at the point of care, reducing medication errors. CHANGJIANG LIDS supports custom color matching and can provide color consistency data across production batches.

Q6: What documentation is available to support regulatory submissions?

CHANGJIANG LIDS provides a comprehensive documentation package including: Certificate of Analysis (CoA), Certificate of Conformance (CoC), material safety data (raw material CoAs and heavy metal test reports), dimensional drawings, and extractables/leachables data. Customers requiring Drug Master File (DMF) support or CEP assistance can contact our technical team. Our ISO 9001:2015 certification and GMP compliance records are available for customer audits.

Q7: What is the minimum order quantity (MOQ) and lead time?

Standard MOQs and lead times vary by cap size, color, and customization requirements. With an annual production capacity of 3 billion aluminum and aluminum-plastic caps, CHANGJIANG LIDS is equipped to fulfill both high-volume commercial orders and smaller validation batches. Contact our sales team for specific pricing and delivery schedules tailored to your project requirements.

Q8: How should I troubleshoot if caps are causing capping machine jams?

Machine jams are most commonly caused by dimensional variation exceeding equipment tolerances, improper hopper orientation, or contaminated/deformed caps. Recommended troubleshooting steps include: (1) verify cap lot dimensions against the equipment's qualification specifications; (2) inspect the hopper and chute for debris; (3) check capping head wear and alignment; (4) review storage conditions to rule out cap deformation from humidity or temperature. CHANGJIANG LIDS' technical support team can assist with root cause analysis and provide dimensional data from the relevant production lot.